Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Liabilities and Shareholders Equity (2024 - 2025)

Historic Liabilities and Shareholders Equity for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $246.7 million.

  • Kestra Medical Technologies' Liabilities and Shareholders Equity changed N/A to $246.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $916.7 million, marking a year-over-year increase of 189511.63%. This contributed to the annual value of $295.7 million for FY2025, which is 54363.53% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Liabilities and Shareholders Equity stood at $246.7 million for Q4 2025.
  • Kestra Medical Technologies' Liabilities and Shareholders Equity's 5-year high stood at $295.7 million during Q2 2025, with a 5-year trough of $45.9 million in Q2 2024.